Hellerup, Denmark

Eva Steiness

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 1.5

ph-index = 1

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 2006-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Eva Steiness: Innovator in Peptide Research

Introduction

Eva Steiness is a prominent inventor based in Hellerup, Denmark. She has made significant contributions to the field of peptide research, particularly in the treatment of various health conditions. With a total of four patents to her name, her work has garnered attention in the scientific community.

Latest Patents

Among her latest patents, Eva has developed IL-4 derived peptide fragments for use in the treatment of diabetic nephropathy. This innovative approach focuses on utilizing peptide fragments derived from interleukin-4 (IL-4) to address the complications associated with diabetic nephropathy. Additionally, she has created IL-4 derived peptides for use in the treatment of obesity, showcasing her commitment to tackling pressing health issues through scientific innovation.

Career Highlights

Throughout her career, Eva has worked with notable companies such as Serodus Aps and Wyeth. Her experience in these organizations has allowed her to refine her expertise and contribute to groundbreaking research in her field.

Collaborations

Eva has collaborated with esteemed colleagues, including Peter Holme Jensen and Bjarne Due Larsen. These partnerships have further enriched her research and development efforts.

Conclusion

Eva Steiness stands out as a dedicated inventor whose work in peptide research has the potential to impact the treatment of diabetes and obesity. Her innovative patents and collaborations reflect her commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…